We found that saposin C, in a dose-dependent manner, increased procaspase-3 and PARP levels and decreased the cleaved form of caspase-9 and -3 and PARP (a caspase-3 substrate) in both AS and AI prostate cancer cells. The gene discussed is CASP9; the disease is prostate carcinoma.